Gloshell
Ingredients

Ingredient Dictionary

DIHYDROMYRCENYL ACETATE

Molecular structure

Definition

US FDA substance register · UNII W9O6R2H72I · registered name DIHYDROMYRCENYL ACETATE · single chemical substance

Source: US FDA Unique Ingredient Identifier (UNII)

Cosmetic roles

Gives the product a scentPERFUMING

Safety & regulatory references

Not classified under Korea’s toxic-substance GHS list · existing chemical substance

Source: Korea toxic substances GHS register (NIER)

More data — names, identifiers, properties, test records, literature

Names & identifiers

DIHYDROMYRCENYL ACETATEINCI7-Octen-2-ol, 2,6-dimethyl-, acetateSynonym
CAS No.chemical registry number
53767-93-4
EC No.EU chemical inventory number
258-751-7
DTXSIDUS EPA chemical ID
DTXSID4052182
DTXCIDUS EPA compound ID
DTXCID4030752
IUPAC
2,6-Dimethyloct-7-en-2-yl acetate
Molecular formula
C12H22O2
Molecular weight
198.306 g/mol

What products actually use it for

What the 6 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

  • Fragrance4
  • Deodorizer2

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

2 skin studies and 1 eye studies are on record.

Classed as moderate1Classed as low1

The studies disagree (the most common conclusion covers 50%), so they do not establish that this ingredient is irritating. These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 3 studies
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: method described by the Magnusson and Kligman "allergic contact dermatitis in the guinea pigs" "allergic contact dermatitis in the guinea pigs" Ed Ch. C. Thomas Springfield, Illinois, USA (1970)
  • Moderate or Mild Irritation
    skin irritation: in vivo · Screening · other guideline: FDA of the United States FDA of the United States (Fed. Reg .28 (119), 5582 1963) according to other guideline: Draize and Kelley Draize and Kelley (Drug Cosmet. Industr. 71 (1952) 36) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: FDA of the United States FDA of the United States (Fed. Reg .28 (119), 5582 1963) according to other guideline: Draize and Kelley Draize and Kelley (Drug Cosmet. Industr. 71 (1952) 36) according to

Source: US EPA CompTox dashboard

Linked databases 9